Pharmacoeconomics of Influenza Vaccination for Healthy Working AdultsReviewing the Available Evidence

被引：0
作者：
Maarten J. Postma
Paul Jansema
Marianne L. L. van Genugten
Marie-Louise A. Heijnen
Johannes C. Jager
Lolkje T. W. de Jong-van den Berg
机构：
[1] University of Groningen Research Institute of Pharmacy (GUIDE/GRIP),Groningen University Institute for Drug Exploration
[2] National Institute of Public Health and the Environment (RIVM),undefined
来源：
Drugs | 2002年 / 62卷
关键词：
Influenza; Indirect Cost; Influenza Vaccination; Indirect Benefit; Pharmacoeconomic Evaluation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
A favourable pharmacoeconomic profile has been well established for influenza vaccination in the elderly. For employers relevant benefits seem to exist for vaccinating healthy working adults to avert absenteeism and related production losses. From a pharmacoeconomic point of view it is relevant to consider whether societal benefits of vaccination for healthy working adults is worthwhile given the costs of vaccination for the community.
引用
收藏
页码：1013 / 1024
页数：11
相关论文
共 112 条
  • [71] Kelly H(undefined)undefined undefined undefined undefined-undefined
  • [72] Bridges CB(undefined)undefined undefined undefined undefined-undefined
  • [73] Meltzer MI(undefined)undefined undefined undefined undefined-undefined
  • [74] Thompson WW(undefined)undefined undefined undefined undefined-undefined
  • [75] Demicheli V(undefined)undefined undefined undefined undefined-undefined
  • [76] Jefferson T(undefined)undefined undefined undefined undefined-undefined
  • [77] Rivetti D(undefined)undefined undefined undefined undefined-undefined
  • [78] Laupacis A(undefined)undefined undefined undefined undefined-undefined
  • [79] Feeny D(undefined)undefined undefined undefined undefined-undefined
  • [80] Detsky AS(undefined)undefined undefined undefined undefined-undefined
3456789101112